Weekly Top Stories: Patented Medicine Prices Review Board’s 2023 Annual Report
As there are reports on medicine sales, patients continue to face significant financial barriers while both public and private sectors propose new solutions. The Patented Medicine Prices Review Board’s 2023 Annual Report, tabled by Federal Health Minister Mark Holland to the Senate and House of Commons on December 6, 2024, reveals detailed trends in Canada’s patented medicine landscape. Sales of patented medicines reached $19.9 billion, representing 47% of total medicine sales, while research and development spending amounted to $1.07 billion, with a sales-to-R&D ratio of 3.7%. Canadian list prices for patented medicines were among the highest globally, ranking fourth in the OECD. The PMPRB reported 1,146 patented medicines, including 86 new ones, and accepted five voluntary undertakings to address pricing concerns. In related news, Health Canada has announced a 2.7% adjustment to fees under the 2020 Fees in Respect of Drugs and Medical Devices Order, set to take effect April 1, 2025. This annual adjustment,required by subsection 30.61(1) of the Food and Drugs Act, reflects changes in the Consumer Price Index (CPI) over the past 12 months, as determined by Statistics Canada. The impact of healthcare costs on patients is highlighted in a new Canadian Cancer Society report, which reveals that cancer patients face average lifetime expenses of nearly $33,000, including costs for medications, travel, and lost income during treatment. Several cancer patients shared their stories of spending $15,000 to $20,000 out of pocket for cancer-related expenses due to the limitation of provincial healthcare coverage. While Canada’s healthcare system covers the cost of surgery and chemotherapy, other expenses such as prescription drugs and travel for treatment are not fully funded, leaving patients with substantial financial burdens. The financial impact also extends to caregivers, with the total cost attributed to patients and caregivers estimated at $7.5 billion in 2024, representing 20% of the total cancer costs in the country. Addressing healthcare access challenges, GreenShield, Canada’s national non-profit health and benefits company, has released its Health Outcomes Report, “Measuring Better Health for All.” The report highlights initiatives, including telemedicine resolving 92% of health issues in first appointments and addressing mental health, which accounts for 70% of workplace disability costs. The company announced plans to reinvest $75 million by 2025 to support over one million Canadians in areas like mental health and chronic disease management. Meanwhile, Ontario Premier Doug Ford has introduced new legislation addressing public health and social challenges, particularly focusing on homeless encampments and public drug use. The plan includes stricter trespassing laws with fines up to $10,000 or six months in jail for public drug use, while also considering rehabilitation options for minor drug offences. Ontario is also investing $75.5 million to support homelessness prevention and offer alternatives to encampments. This adds to the province’s annual $700 million investment in homelessness programs and $378 million for 19 Homelessness and Addiction Recovery Treatment (HART)Hubs However, critics, including Green Party leader Mike Schreiner, argue that housing, not fines or jail, is the solution to homelessness. Critics online are concerned that criminalizing addiction and homelessness will worsen people’s struggles and hinder their chances for employment. MPP Jessica Bell tweeted that the Conservatives are blaming the poor instead of investing in housing, addiction treatment, and healthcare. While, MPP Dr. Adil Shamji criticized Ford for creating a”park to prison pipeline,” saying the plan to fine or imprison people in encampments won’t help those struggling with homelessness, mental health, and addiction. Community organizer Brandon Rhéal Amyot also criticized Ford’s plan, calling it a mix of inadequate funding and punitive measures that would worsen the issues it aims to solve. He described the plan as “handcuffs instead of housing” and “handcuffs instead of harm reduction.” As private sector initiatives like GreenShield work to improve access through digital solutions, debates persist about the most effective approaches to addressing healthcare and related social challenges. The contrast between rising healthcare costs and ongoing accessibility issues underscores the need for balanced, comprehensive solutions that consider both economic and social impacts. Book a free consultation today with Delphic Research!
Weekly Top Stories: Ontario’s Auditor General Reveals Gaps in 2024 Annual Report Amid Rising Healthcare and Economic Challenges
From critical oversight findings to emerging health concerns, this week’s developments reveal mounting pressures on Canada’s healthcare system. As government audits expose policy gaps and outdated strategies, new data highlights the evolving challenges in public health, mental wellness, and healthcare delivery across generations. The Auditor General of Ontario’s 2024 Annual Report criticized several of the province’s programs and policies, including its opioid strategy, redevelopment of a spa and waterpark, government advertising, and land-use planning through the Minister’s Zoning Orders (MZO). Calling Ontario’s opioid strategy outdated, Auditor General Shelley Spence recommended developing a new comprehensive plan to deal with the crisis. The province’s current drug strategy has not been updated since 2016. The report highlighted the Ford government’s closure of 10 safe consumption sites and the plan to open 19 Homelessness and Addiction Recovery Treatment Hubs for supportive housing and addiction recovery beds. Ontario government officials, including Deputy Premier Sylvia Jones, Treasury Board President Caroline Mulroney, Municipal Affairs and Housing Minister Paul Calandra, and Infrastructure Ontario President and CEO Michael Lindsay, held a news conference on December 3 in response to the Auditor General’s report. The officials said they will review the report and exercise prudent fiscal management based on the recommendations. Federal Innovation, Science, and Industry Minister François-Philippe Champagne acknowledged the Auditor General’s report and assured that the government will take action. The minister pledged to improve the transparency of ITB Policy by providing more information, updating the performance measurement, and collaborating in reviewing Key Industrial Capabilities. In a post on X, The Drug Strategy Network of Ontario said the report on provincial drug strategies, including challenges with supervised consumption sites (CTS) and other initiatives, was not flattering. On December 1, World AIDS Day and Indigenous AIDS Awareness Week, the Public Health Agency of Canada expressed its continuing commitment to providing equitable access to HIV testing, treatment, and care. According to the agency’s statement, positive HIV diagnoses have increased by 35% from 2022 to 2023, driven by increased access to testing post-pandemic. Chief Public Health Officer Dr. Theresa Tam reaffirmed Canada’s goal to end HIV as a public health concern by 2030. Canada, like other high-income countries, observed increasing infections amid a global decline. Research scientist Austin Carter of the University of Washington’s Institute for Health Metrics and Evaluation reported that the spike is caused by the increase in high-risk populations, coupled with the decrease in “interest in HIV care”. The situation is particularly concerning in Saskatchewan, which recorded three times the national average of 19.4 new HIV infections per 100,000 people. “With the numbers escalating exponentially, we can’t keep up. We just don’t have the capacity in the health system,” said the University of Saskatchewan’s Head of Infectious Diseases, Satchan Takaya. The healthcare landscape faces additional challenges, as revealed in Dialogue’s year-end report on generational well-being. The analysis from the telemedicine company shows concerning trends among Generation Z Canadians and suggests that worsening worker mental health offers employers and plan sponsors an opportunity to rethink traditional benefits, this is supported by insights from the World Health Organization’s Well-Being Index. The report showed that Canadians ages 20 to 29 have low well-being scores due to sleep deprivation, lack of physical activity, and financial stress. These findings align with broader national trends, as Statistics Canada and the Canadian Social Survey report a decline in high-life satisfaction among Canadians from 54% in mid-2021 to 48.6% in 2024, with particularly sharp declines among those aged 25-34. Employers are also urged to invest in virtual mental health services to empower employees to improve well-being. Against this backdrop of domestic health challenges, Conservative Leader Pierre Poilievre has called for an enhanced border security plan in response to U.S. President-elect Donald Trump’s tariff threats on Canadian imports. Poilievre calls for action on illegal drug trafficking, visa regulations, and more provincial law enforcement collaboration. He proposed expanding patrols, using advanced technology, and limiting asylum seekers to address the refugee backlog. Poilievre criticized Prime Minister Trudeau’s handling of border security, stressing the urgency of Trump’s taking office. The Globe and Mail reported that the focus of drug trafficking between Canada, Mexico, and the U.S. has shifted, particularly concerning fentanyl. While the U.S. Drug Enforcement Administration (DEA) warned in 2015 about Canada’s role in MDMA smuggling, by 2024, U.S. law enforcement data points to Mexico as the primary source of fentanyl. In 2023, only a small amount of fentanyl was seized at the U.S.-Canada border, compared to nearly 10 tonnes at the U.S.-Mexico border. Despite this, U.S. President-elect Donald Trump used drug trafficking from both countries as justification for a 25% tariff on imports. The data, however, shows that Mexico is the main source, exposing a gap between political claims and the facts. The various reports and findings this week underscore the need for updated strategies and evidence-based approaches across the healthcare system. Stay informed with Delphic Research as we continue to analyze these critical developments. Book a free consultation today!
Weekly Top Stories: Studies Reveal Growing Healthcare Access Challenges as Economic Uncertainties Loom
New research this week paints a troubling picture of healthcare accessibility in Canada, revealing deep-rooted barriers that prevent many Canadians from seeking essential care. From basic health services to prescription medications, the gap between healthcare availability and actual access continues to widen, even as potential economic challenges threaten to further complicate the landscape. A recent Blue Cross study has uncovered a concerning disconnect in healthcare utilization. Despite Canadians actively pursuing personal health improvements through balanced diets and regular exercise, nearly half, or 48%, are avoiding professional health services due to perceived barriers such as fear, anxiety, lack of time, and transportation issues. The study emphasizes that individuals with health benefits are more likely to seek necessary care and report better health outcomes. Notably, the rise in virtual care and pharmacist consultations presents new solutions to accessing healthcare, especially benefiting younger generations and addressing transportation and appointment scheduling challenges. The challenges extend beyond basic healthcare access to medication adherence. A new study published in the Canadian Medical Association Journal (CMAJ) has highlighted that approximately 5% of Canadians aged 12 and above experience cost-related nonadherence, leading them to skip doses, reduce dosages, delay refills, or avoid filling prescriptions altogether due to financial constraints. The research reveals concerning disparities, with Indigenous people and other racial groups showing higher rates of nonadherence compared to white respondents. While Quebec residents benefiting from the province’s specific drug insurance program, were found to be least affected by prescription costs. Supporting these findings, Arthritis Research Canada has released complementary research highlighting how financial constraints particularly impact patients with chronic conditions like arthritis. The study reveals that marginalized groups and women are disproportionately affected by medication costs. An analysis of the Canadian Community Health Survey also estimated that Canadians paid $7.4 billion in out-of-pocket for medications, including the total prescription drug expenditures. Against this backdrop of healthcare access challenges, the Canadian Life and Health Insurance Association (CLHIA) has issued a strong warning about potential policy changes that would eliminate employer-paid virtual care services. With 10 million Canadians currently accessing virtual care through employer-paid health benefits, the CLHIA emphasizes that reducing these services could negatively impact health outcomes and further strain Canada’s already overwhelmed healthcare system. Canada’s universal healthcare system covers only doctors and hospitals, leaving services like psychology and prescription drugs reliant on private insurance or personal finances. A new analysis revealed that nearly $4 billion in public funds are lost annually due to federal and provincial subsidies for employer-provided private health insurance, raising questions about whether these funds could be better used to expand universal coverage, such as for pharmacare or accessible virtual care. Adding to these domestic healthcare challenges, President-elect Donald Trump’s announcement of 25% tariffs on Canadian imports has raised concerns about potential impacts on healthcare funding and development. During an urgent virtual meeting with Prime Minister Justin Trudeau, provincial leaders expressed specific worries about healthcare implications. Manitoba Premier Wab Kinew emphasized that the proposed tariff could trigger a recession that would affect the province’s ability to maintain progress on healthcare, education, and other investments. He also noted that the drug trade in Manitoba and Canada must be addressed without needing tariffs. These interconnected challenges – from individual barriers to systemic issues and international economic pressures – signal a critical moment for Canadian healthcare. As the country grapples with improving accessibility while facing potential economic challenges, the need for innovative solutions has never been more apparent. Learn more about our Executive Daily Briefing, and book a free consultation today.
Weekly Top Stories: Quebec Announces Fall 2024 Economic Update; and Alberta’s 2024-25 Fiscal Update
This week reveals stark contrasts in healthcare funding approaches, mounting cost pressures, and evolving strategies for healthcare delivery. From Quebec’s fiscal constraints to Alberta’s Resource-Driven surplus, the healthcare landscape reflects shared challenges in meeting growing healthcare demands. Quebec’s Fall 2024 Economic Update presents a sobering picture of healthcare financing challenges. Finance Minister Eric Girard’s announcement of a $2.1 billion investment over five years comes amid increasing healthcare expenditures and a soaring deficit. In 2024-2025, government portfolio expenditures are projected to grow by 6.5%, driven by rising costs in healthcare and social services, education, and higher education, along with unplanned expenses such as flood-related damages. In particular, healthcare and social services expenditures are set to rise by 3%, with $750 million from the contingency reserve used to address increased labour costs in the sector. Economic forecasts showed improvement, with GDP growth revised upward to 1.2% for 2024 and projected at 1.5% for 2025, while the living standards gap with Ontario has narrowed to 11.1% from 15.9% in 2018. The government will implement a 2.85% optimization of the tax system and its benefits, providing $5.2 billion in household relief over five years. Additionally, $3.4 billion in tax expenditures will be reduced, including aligning capital gains taxation with federal changes and adjusting the career extension tax credit to better fit the labour market. The current accounting deficit stands at $8.8 billion (1.4% of GDP), with Quebec maintaining its commitment to achieving a balanced budget by 2029-30. Long-term fiscal goals include reducing the net debt burden from the current 39% to 30% of GDP by 2037-38. A contingency reserve of $750 million for 2024-25 (increasing to $1.5B annually) has been established to protect against economic uncertainties. The response from Quebec stakeholders has been mixed. The Council of Canadian Innovators, while praising Quebec’s support for innovation, warns that$1 billion in healthcare cuts could hamper research progress. Opposition parties have been more critical, accusing the government of underestimating the deficit and prioritizing “frivolous” spending over public services. Quebec Liberal Party claims the real deficit could be $15 billion, while Québecsolidaire warns of creeping austerity, and the Parti Québécois condemns inefficiencies like the Santé Québec agency. Quebec’s decision to raise the eligibility age for the tax credit for career extension to 65 has sparked concerns among business groups, who warn it may worsen labour shortages and discourage workforce retention. In contrast, Alberta’s 2024-25 Second Quarter Fiscal Update and Economic Statement tells a different story. Alberta Finance Minister Nate Horner announced a projected $4.6 billion surplus for the current fiscal year, higher than the first quarter forecast of $2.9 billion, driven by increased income tax revenue from population growth and oil and gas royalties. However, the province faces its own healthcare challenges, with expenses projected to increase by $716 million due to population growth, an aging population, and higher demand for physician services, including more fee-for-service billings. An additional $451 million will support rising patient numbers and their complex needs, while $265 million will be allocated to Alberta Health Services for expanded services such as lab tests, urgent care, and family health access. Alberta’s rapid population growth of 4.4%(207,000 people) between July 2023-2024 has already consumed the province’s $2 billion contingency fund, with significant portions directed to healthcare and education. Despite expectations of reduced population growth to 2.5% next year due to lower federal immigration targets, unemployment is projected to rise from 7.2% in 2024 to 7.4% in 2025, highlighting challenges in absorbing the rapid population expansion into the labour market. The Council of Canadian Innovators has emphasized the need for the province to finalize strategies for privacy policy and intellectual property commercialization to foster innovation, particularly in health technology procurement. While experts from the Fraser Institute cautioned that the province’s reliance on volatile resource revenues leaves its finances vulnerable to downturns, with a slight drop in oil prices potentially pushing the government back into deficit. Critics argued that the Smith government must reduce spending to avoid repeating the cycle of rising expenditures during resource booms, which has historically led to deficits when revenues decline. Against this backdrop of provincial funding challenges, a new report from GreenShield, a Canadian national non-profit health and benefits organization, highlights a concerning trend in healthcare costs. Their “2024 Drug Trends Report” reveals a substantial $300 million increase in total drug costs, driven by rising demand for medications related to obesity, diabetes, and mental health. The report emphasizes the growing role of pharmacists in prescription initiation and underscores the critical need for accessible drug coverage to address Canada’s escalating chronic health conditions. Amid these financial and healthcare delivery challenges, the Canadian Dental Association (CDA) has achieved international recognition, winning gold at the 2024 Global Facilitation Impact Award for its”2024-2029 Forward Focus Strategic Plan.” The award acknowledges the plan’s collaborative approach and forward-thinking objectives, developed through extensive stakeholder engagement across Canada. The CDA’s “Forward Focus” strategic plan on improving oral health access, supporting dentists, and ensuring proactive engagement on national dental issues represents a bright spot in Canadian healthcare planning. As provinces wrestle with healthcare funding decisions and organizations grapple with rising costs, these developments underscore the complex interplay between fiscal management, healthcare delivery, and long-term planning. Book a free consultation today to learn how these healthcare trends and policy shifts might impact your organization’s strategic planning and operations.
Weekly Top Stories: Life Sciences Ontario Ideas to Action Forum Celebrates 15th Year
This week in Canadian healthcare, major provincial investments in life sciences contrast with ongoing challenges in healthcare delivery and access, highlighting the promise and current limitations of our healthcare system. The Life Sciences Ontario (LSO) Ideas to ActionForum marked its 15th anniversary with a sold-out gathering on November 13th atBorden Ladner Gervais LLP, bringing together influential voices from industry,government, and academia. The forum, themed “Reflecting on 15 Years andPowering Ontario’s Hard Pivot to the Future,” emphasized Ontario’sgrowth, innovation, and resilience in the life sciences sector. Deloitte’s Health Futurist Zayna Khayat opened the event with a keynote examining the evolution of health technology while emphasizing the need for system leaders, industry governments, and healthcare providers to fundamentally change their thinking to overcome an epidemic of”nowism.” The forum featured several expert panels addressing core themes shaping the sector: The event culminated with significant announcements from Ontario’s Minister of Economic Development, Job Creation, and Trade, Vic Fedeli. Minister Fedeli hinted that further announcements are coming to support the province’s “hard pivot” to the life sciences. Fedeli highlighted Ontario’s impressive metrics:72,000 current life sciences workers with a goal of reaching 85,000 by 2030, complemented by 70,000 STEM graduates and 85,000 AI graduates. He noted that Ontario hosts 10 of the world’s top pharmaceutical companies conducting clinical trials, reinforcing its potential as a global hub for biomanufacturing and life sciences. Fedeli praised LSO and its leadership, particularly acknowledging Dr. Jason Field, President and CEO of LSO, for his dedication to Ontario’s life sciences growth. While Ontario pushes forward with ambitious life sciences initiatives, a new study reveals significant gaps in current healthcare delivery. Research from the Menopause Foundation of Canada has highlighted a concerning disconnect in women’s healthcare support, finding that approximately half of the Canadian women aged 40-60 feel unprepared for perimenopause/menopause. The findings underscore a critical gap in healthcare delivery, with most respondents reporting that family physicians rarely discuss menopause with them, leading to a sense of being undertreated and underserved by their healthcare providers. Adding to concerns about healthcare access and administration, federal retirees shared their concerns about the recent transition of their dental benefits from Sun Life to Canada Life. The $ 514 million contract switch, affecting approximately 1.7 million federal public servants, retirees, and their dependents, has encountered implementation difficulties.Several retirees experienced frustration due to the transition, citing that they could not reach a call centre agent and were denied medications. The Treasury Board Secretariat (TBS) asserted that lessons learned from the Public Service Health Care Plan transition were applied to facilitate a smoother switch for the dental plan. These developments paint a complex picture of Canadian healthcare; while significant investments promise future innovations, current gaps in healthcare delivery and program administration continue to affect Canadians’ access to essential services. Stay tuned to Delphic Research for further insights into these critical healthcare developments. Book a free consultation today to learn how we can help you understand these trends that might impact your organization or community.
Weekly Top Stories: Trump Victory Signals Potential Shifts in Canada-U.S. Healthcare Relations
As Donald Trump secures his return to the White House, Canada’s healthcare landscape faces potential transformation. From drug pricing to cross-border medical cooperation, stakeholders across the country are preparing for a new chapter in Canada-U.S. healthcare relations. Prime Minister Justin Trudeau’s congratulatory statement emphasized the strong and longstanding partnership between Canada and the U.S., highlighting their shared history and the successful renegotiation of the Canada-U.S.-Mexico Agreement(CUSMA) under Trump’s first term, noting that bilateral trade has surged, reaching over $1.3 trillion in 2023. The Canadian Chamber of Commerce, through president and chief executive officer Candace Laing, reinforced the importance of preserving this economic partnership, noting the $3.6 billion in daily trade while urging close collaboration to resist potential tariffs and trade barriers. As Canadian cabinet ministers call for calm amid Trump’s promises of tariffs and tighter immigration policies, InnovationMinister François-Philippe Champagne has assured industries that Canada’s strategic importance in sectors like critical minerals and energy will remain a priority in future trade negotiations. Provincial leaders are also taking action, with Ontario Premier Doug Ford and Economic Development Minister Vic Fedeli planning a “charm offensive” in Washington and key U.S. states to promote Ontario’s critical minerals, energy, and electric vehicle manufacturing. Meanwhile, Manitoba Premier Wab Kinew has emphasized the value of Manitoba goods and critical minerals for the American defence sector, despite concerns over Trump’s proposed 10% tariffs. The healthcare sector faces particular uncertainty under Trump’s second-term agenda. His campaign hinted at revisiting policies from his first term, including international reference pricing for drugs and potential changes to the Affordable Care Act. Some sectors fear that the U.S. Medicaid program could face cuts as Republicans seek spending reductions to extend Trump’s 2017 tax cuts. However, the program’s shift to private insurers and support from rural hospitals may offer some protection. Analysts discussing these developments in this week’s Canada-U.S. newsletter analysts discussed how Trump’s re-election could challenge Canadian competitiveness, particularly with the threat of new tariffs and trade tensions. Experts warned that Trump’s aggressive economic policies, including tariffs and defence spending demands, could strain Canada’s economy and its relationship with the U.S. However, former New Jersey governor Chris Christie argued that Canada could benefit from aligning more closely with Trump’s pro-growth policies, which emphasize reducing barriers to business and fostering a thriving private sector. Against this backdrop of international uncertainty, Canada’s own healthcare spending is projected to reach unprecedented levels. The Canadian Institute for Health Information’s annual report reveals healthcare expenditures will hit $372 billion in 2024, equating to $9,054 per capita. This 5.7% increase follows a trend of rising health expenditures in recent years, driven by the growing and aging population. The introduction of new federal programs such as dental and Pharmacare plans is expected to further increase costs as more Canadians gain access to essential health services. Health spending is also forecast to account for 12.4% of Canada’s gross domestic product, the highest level outside of the pandemic years. These rising costs mirror growing public concerns. The Salvation Army’s “2024 Canadian Poverty and SocioeconomicAnalysis” reveals healthcare as a primary worry among Canadians, with 59% of respondents ranking it as their top concern. The survey, gathering data from over 1,500 Canadians, indicates that healthcare anxieties extend beyond mere cost-of-living challenges, intertwining with other social issues like housing insecurity at 44%. As Canada navigates these challenges, there’s growing support for innovative healthcare solutions. An online survey by spark*insights reported that about 80% of Canadians deem it crucial for their health benefits plan to cover virtual care. Among 1,815 adult respondents, about two-thirds hope for federal government intervention to encourage employer-provided virtual care benefits. This push for digital health solutions suggests a desire to strengthen Canada’s independent healthcare capabilities amid international uncertainty. Meanwhile, Statistics Canada unveiled in a recent survey that the majority of First Nations People, Métis, and Inuit found it crucial to include Indigenous traditional medicines and wellness practices in healthcare services. The survey also emphasized that nearly one in five Indigenous people experience unfair treatment, racism, or discrimination from healthcare professionals, limiting their access to quality care. As Canada balances international pressures with domestic healthcare priorities, these developments underscore the complex challenges ahead. Stay tuned to Delphic Research for ongoing analysis of how these changes might reshape Canada’s healthcare landscape. Book a free consultation today!
Weekly Top Stories: Ontario Announces Major Healthcare Investments in 2024 Fall Economic Statement
Healthcare funding and accessibility dominated this week’s news, as Ontario announced substantial investments in its Fall Economic Statement. Meanwhile, reports of treatment barriers and care gaps across the country highlight the ongoing challenges in Canada’s evolving healthcare landscape The Ontario government’s 2024 Fall Economic Statement unveiled healthcare investments as part of its broader economic plan. A cornerstone of these initiatives is a $546 million investment in improving primary healthcare, aiming to connect 600,000 people to team-based care. This commitment represents a significant step toward addressing healthcare access issues in the province. In a targeted initiative for those with amyotrophic lateral sclerosis (ALS), the government is committing $13 million over three years to establish a comprehensive provincial program. This funding will support five regional multidisciplinary ALS clinics, including a notable expansion into Northern Ontario, while exploring an assistive devices loan and recycling program for those with physical disabilities. Ontario Premier Doug Ford welcomed ALS Canada to Queen’s Park to discuss the life-changing impact this funding will have on residents battling ALS. Fertility services are also receiving significant attention, with a $150 million investment to expand the Ontario Fertility Program. This expansion will nearly triple access to government-funded IVF cycles, while a new tax credit planned for 2025 will cover 25% of eligible fertility treatment expenses, supported by a $115 million allocation. The province’s commitment to healthcare infrastructure remains substantial, with nearly $50 billion dedicated to this, including $36 billion for over 50 hospital projects and 3,000 new beds. However, these investments have drawn mixed reactions from stakeholders. The Toronto Region Board of Trade expressed support for the investments in high-productivity industries and manufacturing, commending the expansion of the Invest Ontario Fund and ongoing infrastructure projects. However, it advocated for more substantial investments in productive capacity over cash rebates to enhance long-term economic prosperity. The Canadian Life and Health Insurance Association (CLHIA) welcomed the commitment to introduce a new licensing category for managing general agents. This initiative will enhance consumer protection and clarify accountabilities within the insurance industry, ultimately leading to fairer outcomes for Ontarians. In contrast, the Ontario NDP, led by Marit Stiles, criticized the economic statement, arguing that instead of addressing key issues like healthcare access, the provincial government offers only distractions and empty promises. Similarly, the Ontario Liberals, MPP for Ottawa South John Fraser, slammed the statement for prioritizing wealthy insiders over real investments in healthcare and financial relief. Ontario Greens Leader Mike Schreiner also criticized the Ford government for failing to address rising costs, housing shortages, and climate change. On a similar note, Ontario’s community health sector, representing over 200,000 workers, has expressed disappointment over the government’s failure to address a $2 billion wage gap that affects care quality, especially in areas like mental health and addictions, and is calling for investments to close this gap and establish sustainable workforce support through collaborative efforts by associations including Addictions and MentalHealth Ontario (AMHO) among others. These concerns about healthcare access are reflected in national statistics. Canadian think tank SecondStreet reveals that more than 3.2 million Canadians lack access to basic healthcare services, including surgeries and appointments with experts. In Ontario specifically, while waitlist volumes have decreased by 19%, diagnostic waitlist volumes have seen a troubling 32% increase. Breast Cancer Canada’s 2024 progress report also highlights the challenges in cancer care accessibility, highlighting the urgent need for equitable access to breast cancer care across Canada. Some of the gaps identified include accessible routine screening, the financial impact on families, and the latest treatments. The challenges of healthcare access are particularly acute for Canadians with rare diseases. Despite Health Canada’sapproval of innovative treatments for conditions like spinal muscular atrophy(SMA), approximately one million Canadians diagnosed with rare disorders continue to face the lack of treatment access despite approvals from HealthCanada. Innovative treatments such as Spinraza, Zolgensma, and Evrysdi have been approved by the government as safe and effective. However, age limits on these drugs continue to cause financial strain to adults with SMA due to denied coverage. Against this backdrop of healthcare access challenges, the implementation of the Pharmacare Act promises potential relief. The Act aims to reduce financial burdens by providing free access to essential medications, including contraceptives and diabetes medications. However, its success depends on the federal government’s ability to secure agreements with individual provinces and territories. In British Columbia, where free access to contraceptives has been available since 2023, advocacy groups, including the Council of Canadians and AccessBC, shared their concern that the program could be dissolved by an incoming Conservative government if the federal government failed to secure agreements as soon as possible. Book a free consultation today to learn more about how these healthcare developments might impact your organization or community.
Weekly Top Stories: Provincial Support for Pharmacare Remains in Focus as Federal Government Faces Implementation Challenges
The implementation of Pharmacare continues to dominate discussions, while significant investments in research and accessibility initiatives signal progress in other areas of healthcare development. The federal government’s optimism about Pharmacare is being met with mixed reactions across the country as the New Democratic Party (NDP) intensifies its calls for provincial participation. In Ontario, the Ministry of Health Sylvia Jones office revealed that it has yet to be notified by the federal government about the pharmacare deal. While expressing willingness to collaborate, the ministry is requesting more detailed information about the legislation before entering negotiations. Meanwhile, Conservative opposition leader Pierre Poilievre faces criticism for allegedly spreading dubious details about the Pharmacare Act. The pharmacare law is accused of abolishing private insurance plans and eliminating health benefits. The urgency for provincial participation is particularly evident in Newfoundland and Labrador, where NDP Candidate for St. John’s East Mary Shortall is pressing for immediate action to finalize a Pharmacare agreement. The push is backed by compelling data: according to Diabetes Canada, 14% of Newfoundland and Labrador residents are diagnosed with diabetes – notably 4% above the national average. The residents currently spend over $70 million on diabetes coverage alone. The Health Charities Coalition of Canada applauded the passage of Pharmacare, citing the bill as a crucial step towards developing a national formulary and bulk purchasing strategy. Chairperson Elizabeth Myles said that Pharmacare will provide relief to 25% of Canadians forced to choose between affording medications and other basic needs. In a significant development for healthcare research, the Canadian Institutes of Health Research shared that the federal government invested $13.7 million in support of 24 research projects that will tackle under-researched areas of women’s and gender-diverse people’s health. The projects that will receive the fund are focused on polycystic ovary syndrome (PCOS), rural and Indigenous perinatal care and breastfeeding, heart health, gender-based violence, mental health, eating disorders, reproductive care and pregnancy, gender-based violence, cancer and HPV, vestibulodynia, and endometriosis. Meanwhile, several reports revealed that Canadians with non-terminal conditions often seek medical assistance in dying (MAID) due to social reasons such as loneliness, isolation, and fear of homelessness. A report from the Associated Press unveiled that the 2021 expansion of MAID caused an increased application from people in the poorest areas of Ontario. A study by Longwoods Publishing called for deep and sustained deliberation in assisted dying policies in Canada, raising important questions about the intersection of healthcare, social support, and end-of-life decisions. On a forward-looking note, the Speech Accessibility Project, led by the University of Illinois Urbana-Champaign, is expanding its reach into Canada with a new recruitment initiative. The project seeks Canadian adults with Parkinson’s disease, cerebral palsy, and amyotrophicis to participate in research aimed at improving speech recognition systems to better understand diverse speech patterns and disabilities. This initiative holds significant potential for enhancing the quality of life for more than 100,000 Canadians living with Parkinson’s disease and other conditions that affect speech, demonstrating continued progress in making healthcare more accessible to all Canadians. Stay tuned to Delphic Research for further insights into these critical healthcare issues. Book a free consultation today to learn more about how these healthcare trends might impact your organization or community.
Weekly Top Stories: Sharon Blady joins PMPRB as a Board Member; and a $146 million Investment in the Next Phase of Life Sciences Strategy
This week in Canadian healthcare saw significant developments in governance, provincial investments, and ongoing debates about pharmacare implementation. From key appointments to major funding announcements and policy discussions, the healthcare landscape continues to evolve rapidly. Federal Minister of Health Mark Holland announced the appointment of Sharon Blady, former Manitoba health minister, to the Patented Medicine Prices Review Board (PMPRB). Set to serve a five-year term, Blady brings over 15 years of experience in healthcare and public policy to the role with a particular focus on mental health and neuroinclusion. As the founder and CEO of Speak Up, a consulting firm specializing in healthcare delivery, mental health education, government relations, and policy analysis, Blady’s expertise is expected to contribute significantly to the PMPRB’s mission. While the federal government strengthens its regulatory oversight, provinces are also taking significant steps to boost healthcare innovation and economic growth. In a major move, the Ontario government has unveiled the next phase of its life sciences strategy, committing $146 million to bolster the province’s position as a global hub for biomanufacturing and health sciences innovation. This new investment builds upon $5 billion in investments and 5,000 jobs created since 2018, focusing on advancing R&D, improving capital access, ecosystem support, and driving healthcare innovation. Key allocations include $46 million for research infrastructure, $15 million for wet labs, and $24 million to scale up life sciences companies. Premier Doug Ford emphasized that the strategy will enhance Ontario’s biomanufacturing capacity and reinforce its status as a primary destination for life sciences investments. Ontario Economic Development Minister Vic Fedeli described the strategy as a “hard pivot” from electric vehicles to life sciences, aiming to increase life sciences jobs from 72,000 to 85,000 by 2030. He also emphasized Ontario’s potential as a leader in nuclear medicine due to its CANDU nuclear reactors and partnerships with leading universities and companies. While provincial initiatives like Ontario’s life sciences strategy aim to boost innovation and economic growth in healthcare, federal policy changes are reshaping the landscape of medication access across the country. The recent passage of Bill C-64, the Pharmacare Act, has ignited a heated debate about its potential impact on Canada’s healthcare system, particularly regarding the coverage of essential medications. While aiming to improve access to prescription drugs, the legislation has drawn criticism from key stakeholders in the healthcare industry. The Canadian Life and Health Insurance Association has voiced strong concerns, suggesting it could potentially jeopardize Canadians’ existing access to vital medications. Stephen Frank, the association’s president and CEO, described the Senate’s decision to pass the bill without amendments as “vague and confusing,” and a disregard for the concerns of stakeholders. As the debate over the Pharmacare Act continues, the federal government is moving forward with its implementation plans. Prime Minister Justin Trudeau announced that negotiations on pharmacare deals between provinces and territories must start as soon as possible after passing the Pharmacare Act into law, with Health Minister Mark Holland expressing confidence in securing agreements with all provinces by spring. The federal government aims to establish bilateral agreements providing universal, single-payer, first-dollar access to birth control and diabetes medications. As part of the implementation process, Holland is also tasked with creating a committee of experts who will make recommendations, which must be provided after a year of receiving Royal Assent. A pan-Canadian strategy detailing the appropriate use of prescription drugs and related products must also be published. Provincial responses vary, with Alberta expressing willingness to discuss despite skepticism, while Saskatchewan’s political parties remain divided on the issue. While pharmacare discussions dominate headlines, efforts to improve healthcare equity and accessibility continue at various levels. The federal government has announced a $2.7 million investment through the Enabling Accessibility Fund (EAF) to enhance accessibility for people with disabilities at the Luso Canadian Charitable Society in Mississauga, Ontario. This project will upgrade infrastructure with accessible washrooms, ramps, an elevator, and a drop-off area, while also creating job opportunities for persons with disabilities. In a related development, Ontario has marked a milestone with the establishment of the first Indigenous-led hospice, providing $1.25 million in funding for the construction of a five-bed hospice that will be used by the Six Nations of the Grand River. Looking beyond current initiatives to future challenges, an independent panel of doctors and researchers expressed the need for urgent preparation for the next health emergency, highlighting the government’s crucial role in taking action. The report stated the importance of effectively communicating disease surveillance, research findings, and hospitalization data between the federal government, provinces, and territories. The panel also emphasized that inequity among Indigenous communities, the homeless, and others during health emergencies should be addressed. As Canada’s healthcare landscape continues to evolve, these developments highlight the ongoing challenges and opportunities in improving healthcare access, equity, and preparedness across the country. Stay tuned to Delphic Research for further insights into these critical healthcare issues, or better, book a free consultation today!
Delphic Research Group Inc. expands Mitchell Pratt’s role to include Program Manager, Directory Assistance.
Delphic Research Group Inc. is pleased to announce that Mitchell Pratt, our Manager of Growth, has also been named Program Manager,Directory Assistance. In this new capacity, Mitch will oversee the development and execution of Delphic Research’s Directory Assistance division, which is dedicated to building knowledge around the people who matter most—decision-makers and influencers in the context of government affairs. The division leverages data-driven strategies to provide customers with superior intelligence,insights, and information about key stakeholders driving policy. As Program Manager, Mitch will take on responsibility for CanGov 411, the first and only application available on both iOS and Android that integrates government directories across Canada. He will lead the charge in developing data-driven stakeholder mapping, exploring predictive analytics, and tapping into behavioral science to offer enhanced tools that help clients better navigate the complex world of government affairs. Mitch’s appointment helps round out our developing program strategy, and he will join Mac Grenier, Program Manager for the Executive Daily Briefing and Subscription Services, and Emmanuel Duwana, Program Manager for The Academy,Delphic Research’s innovative learning management division. These are early days for these new programs, and we are very excited about their potential as we continue to build them out. Mitch brings a wealth of experience to this role. Before joining Delphic Research, he worked in a variety of positions, including at an early-stage startup where he focused on customer success, communications, and product partnerships. Prior to that, Mitch was part of EY Canada’s Business Transformation Consulting team, where he helped clients solve problems with data-driven storytelling. He also led client engagements at Impact Public Affairs and started his career in government relations at Crestview Strategy. His multifaceted background, combined with his strong skills in public affairs,stakeholder relationship management, and political communications, makes Mitch an ideal fit to lead the Directory Assistance division. Jason Grier, CEO of Delphic Research, shared his enthusiasm about Mitch’s expanded role: “I’m really pleased that Mitch is taking on these additional responsibilities. It’s indicative of our commitment to building products that help elevate government affairs through knowledge. We firmly believe that professionals deserve professional tools, and when it comes to government affairs, Delphic Research is at the forefront of building those tools.” At Delphic Research, we continue to elevate government affairs through innovative products, and Mitch’s leadership in Directory Assistance will be a key driver of that mission.